Literature DB >> 27157985

Predicting long-term neurological outcomes after severe traumatic brain injury requiring decompressive craniectomy: A comparison of the CRASH and IMPACT prognostic models.

Stephen Honeybul1, Kwok M Ho2.   

Abstract

BACKGROUND: Predicting long-term neurological outcomes after severe traumatic brain (TBI) is important, but which prognostic model in the context of decompressive craniectomy has the best performance remains uncertain.
METHODS: This prospective observational cohort study included all patients who had severe TBI requiring decompressive craniectomy between 2004 and 2014, in the two neurosurgical centres in Perth, Western Australia. Severe disability, vegetative state, or death were defined as unfavourable neurological outcomes. Area under the receiver-operating-characteristic curve (AUROC) and slope and intercept of the calibration curve were used to assess discrimination and calibration of the CRASH (Corticosteroid-Randomisation-After-Significant-Head injury) and IMPACT (International-Mission-For-Prognosis-And-Clinical-Trial) models, respectively.
RESULTS: Of the 319 patients included in the study, 119 (37%) had unfavourable neurological outcomes at 18-month after decompressive craniectomy for severe TBI. Both CRASH (AUROC 0.86, 95% confidence interval 0.81-0.90) and IMPACT full-model (AUROC 0.85, 95% CI 0.80-0.89) were similar in discriminating between favourable and unfavourable neurological outcome at 18-month after surgery (p=0.690 for the difference in AUROC derived from the two models). Although both models tended to over-predict the risks of long-term unfavourable outcome, the IMPACT model had a slightly better calibration than the CRASH model (intercept of the calibration curve=-4.1 vs. -5.7, and log likelihoods -159 vs. -360, respectively), especially when the predicted risks of unfavourable outcome were <80%.
CONCLUSIONS: Both CRASH and IMPACT prognostic models were good in discriminating between favourable and unfavourable long-term neurological outcome for patients with severe TBI requiring decompressive craniectomy, but the calibration of the IMPACT full-model was better than the CRASH model. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRASH prediction model; Decompressive craniectomy; IMPACT prediction model

Mesh:

Year:  2016        PMID: 27157985     DOI: 10.1016/j.injury.2016.04.017

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  4 in total

1.  Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.

Authors:  Adrian M Svingos; Steven A Robicsek; Ronald L Hayes; Kevin K Wang; Claudia S Robertson; Gretchen M Brophy; Linda Papa; Andrea Gabrielli; H Julia Hannay; Russell M Bauer; Shelley C Heaton
Journal:  Neurocrit Care       Date:  2022-03-01       Impact factor: 3.532

2.  Death after discharge: prognostic model of 1-year mortality in traumatic brain injury patients undergoing decompressive craniectomy.

Authors:  Wenxing Cui; Shunnan Ge; Yingwu Shi; Xun Wu; Jianing Luo; Haixiao Lui; Gang Zhu; Hao Guo; Dayun Feng; Yan Qu
Journal:  Chin Neurosurg J       Date:  2021-04-21

3.  Postoperative complications influencing the long-term outcome of head-injured patients after decompressive craniectomy.

Authors:  Guangfu Di; Yuhai Zhang; Hua Liu; Xiaochun Jiang; Yong Liu; Kun Yang; Jiu Chen; Hongyi Liu
Journal:  Brain Behav       Date:  2018-12-04       Impact factor: 2.708

4.  Genetic Influences on Patient-Oriented Outcomes in Traumatic Brain Injury: A Living Systematic Review of Non-Apolipoprotein E Single-Nucleotide Polymorphisms.

Authors:  Frederick A Zeiler; Charles McFadyen; Virginia F J Newcombe; Anneliese Synnot; Emma L Donoghue; Samuli Ripatti; Ewout W Steyerberg; Russel L Gruen; Thomas W McAllister; Jonathan Rosand; Aarno Palotie; Andrew I R Maas; David K Menon
Journal:  J Neurotrauma       Date:  2019-06-07       Impact factor: 5.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.